Corbus Pharmaceuticals Holdings, Inc. Operating Leases, Rent Expense
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Operating Leases, Rent Expense of $587.96 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2019-03-12
- Corbus Pharmaceuticals Holdings, Inc. operating leases, rent expense for the quarter ending 2018-12-31 was $146.99K, a 0.09% increase year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. operating leases, rent expense for the quarter ending 2018-09-30 was $146.23K, a 57.79% increase year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. operating leases, rent expense for the quarter ending 2018-06-30 was $147.75K, a 152.53% increase year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. operating leases, rent expense for the quarter ending 2018-03-31 was $146.99K, a 151.23% increase year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. operating leases, rent expense for fiscal 2018 was $587.96K, a 64.90% increase from fiscal 2017.
- Corbus Pharmaceuticals Holdings, Inc. operating leases, rent expense for fiscal 2017 was $356.55K, a 55.22% increase from fiscal 2016.
- Corbus Pharmaceuticals Holdings, Inc. operating leases, rent expense for fiscal 2016 was $229.71K, a 313.91% increase from fiscal 2015.
- Corbus Pharmaceuticals Holdings, Inc. operating leases, rent expense for fiscal 2015 was $55.50K, a 56.11% increase from fiscal 2014.
| Period end | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 6 month | Operating Leases, Rent Expense 6 month as first filed | Operating Leases, Rent Expense 9 month | Operating Leases, Rent Expense 12 month |
|---|---|---|---|---|---|
| 2018-12-31 | $146.99K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $293.22K derived: sum of 2 quarters · filed 2019-03-12 | $440.97K derived: sum of 3 quarters · filed 2019-03-12 | $587.96K 10-K · filed 2019-03-12 | |
| 2018-09-30 | $146.23K 10-Q · filed 2018-11-08 | $293.98K derived: sum of 2 quarters · filed 2018-11-08 | $440.97K 10-Q · filed 2018-11-08 | $587.83K derived: sum of 4 quarters · filed 2019-03-12 | |
| 2018-06-30 | $147.75K 10-Q · filed 2018-08-08 | $294.74K 10-Q · filed 2018-08-08 | $441.60K derived: sum of 3 quarters · filed 2019-03-12 | $534.27K derived: sum of 4 quarters · filed 2019-03-12 | |
| 2018-03-31 | $146.99K 10-Q · filed 2018-05-10 | $293.85K derived: sum of 2 quarters · filed 2019-03-12 | $386.52K derived: sum of 3 quarters · filed 2019-03-12 | $445.03K derived: sum of 4 quarters · filed 2019-03-12 | |
| 2017-12-31 | $146.86K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $239.53K derived: sum of 2 quarters · filed 2019-03-12 | $298.04K derived: sum of 3 quarters · filed 2019-03-12 | $356.55K 10-K · filed 2019-03-12 | |
| 2017-09-30 | $92.67K 10-Q · filed 2018-11-08 | $151.18K derived: sum of 2 quarters · filed 2018-11-08 | $209.69K 10-Q · filed 2018-11-08 | $327.51K derived: sum of 4 quarters · filed 2018-11-08 | |
| 2017-06-30 | $58.51K 10-Q · filed 2018-08-08 | $117.02K 10-Q · filed 2018-08-08 | $234.84K derived: sum of 3 quarters · filed 2018-08-08 | $272.51K derived: sum of 4 quarters · filed 2018-08-08 | |
| 2017-03-31 | $58.51K 10-Q · filed 2018-05-10 | $176.34K derived: sum of 2 quarters · filed 2018-05-10 | $214.00K derived: sum of 3 quarters · filed 2018-05-10 | $251.67K derived: sum of 4 quarters · filed 2018-05-10 | |
| 2016-12-31 | $117.83K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $155.49K derived: sum of 2 quarters · filed 2018-03-12 | $193.16K derived: sum of 3 quarters · filed 2018-03-12 | $229.71K 10-K · filed 2018-03-12 | |
| 2016-09-30 | $37.67K 10-Q · filed 2017-11-08 | $75.33K derived: sum of 2 quarters · filed 2017-11-08 | $111.88K 10-Q · filed 2017-11-08 | $125.90K derived: sum of 4 quarters · filed 2018-03-12 | |
| 2016-06-30 | $37.67K 10-Q · filed 2017-08-09 | $74.21K 10-Q · filed 2017-08-09 | $88.24K derived: sum of 3 quarters · filed 2018-03-12 | $102.26K derived: sum of 4 quarters · filed 2018-03-12 | |
| 2016-03-31 | $36.55K 10-Q · filed 2017-05-09 | $50.57K derived: sum of 2 quarters · filed 2018-03-12 | $64.59K derived: sum of 3 quarters · filed 2018-03-12 | $78.32K derived: sum of 4 quarters · filed 2018-03-12 | |
| 2015-12-31 | $14.02K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $28.05K derived: sum of 2 quarters · filed 2018-03-12 | $41.77K derived: sum of 3 quarters · filed 2018-03-12 | $55.50K 10-K · filed 2018-03-12 | |
| 2015-09-30 | $14.02K 10-Q · filed 2016-11-10 | $27.75K derived: sum of 2 quarters · filed 2016-11-10 | $41.47K 10-Q · filed 2016-11-10 | $55.20K derived: sum of 4 quarters · filed 2016-11-10 | |
| 2015-06-30 | $13.72K 10-Q · filed 2016-08-12 | $27.45K 10-Q · filed 2016-08-12 | $27.45K 10-Q · filed 2015-08-13 | $41.17K derived: sum of 3 quarters · filed 2016-08-12 | $49.27K derived: sum of 4 quarters · filed 2016-08-12 |
| 2015-03-31 | $13.72K 10-Q · filed 2016-05-13 | $27.45K derived: sum of 2 quarters · filed 2016-05-13 | $35.55K derived: sum of 3 quarters · filed 2016-05-13 | $43.65K derived: sum of 4 quarters · filed 2016-05-13 | |
| 2014-12-31 | $13.72K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | $21.82K derived: sum of 2 quarters · filed 2016-03-28 | $29.93K derived: sum of 3 quarters · filed 2016-03-28 | $35.55K 10-K · filed 2016-03-28 | |
| 2014-09-30 | $8.10K 10-Q · filed 2015-11-10 | $16.20K derived: sum of 2 quarters · filed 2015-11-10 | $21.82K 10-Q · filed 2015-11-10 | $16.20K derived: sum of 4 quarters · filed 2015-11-10 | |
| 2014-06-30 | $8.10K 10-Q · filed 2015-08-13 | $8.10K 10-Q · filed 2015-08-13 | $8.10K derived: sum of 3 quarters · filed 2015-08-13 | $8.10K derived: sum of 4 quarters · filed 2015-08-13 | |
| 2014-03-31 | $0.00 10-Q · filed 2015-05-13 | $0.00 derived: sum of 2 quarters · filed 2015-05-13 | $0.00 derived: sum of 3 quarters · filed 2015-05-13 | ||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-10 | $0.00 derived: sum of 2 quarters · filed 2015-02-10 | $0.00 10-K · filed 2015-02-10 | ||
| 2013-09-30 | $0.00 10-Q · filed 2014-11-13 | $0.00 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |